GDNF induces recovery of the nigrostriatal dopaminergic system in the rat brain following intracerebroventricular or intraparenchymal administration

Acta Neurochirurgica

Volumn 142, Issue 7, 2000, Pages 805-810

  Aoi, M ^a   Date, Isao ^a   Tomita, S ^a   Ohmoto, T ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Dopamine; GDNF; Parkinson's disease; Regeneration

Indexed keywords

APOMORPHINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; FEMALE; NEUROCHEMISTRY; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ADRENERGIC AGENTS; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIVISION; DISEASE MODELS, ANIMAL; FEMALE; INJECTIONS, INTRAVENTRICULAR; NEUROGLIA; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; SUBSTANTIA NIGRA; VISUAL CORTEX;

EID: 0033948750     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007010070096     Document Type: Article

References (25)

1. 1. Aoi M, Date I, Tomita S, Ohmoto T (2000) The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages. Neurosci Res (in press)
2. 2. Bjorklund A, Rosenblad C, Winkler C, Kirik D (1997) Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol Dis 4: 186-200
3. 3. Bowenkamp KE, Hoffman AF, Gerhardt GA, Henry MA, Biddle PT, Hoffer BJ, Granholm AC (1995) Glial cell line-derived neurotrophic factor supports survival of injured mid-brain dopaminergic neurons. J Comp Neurol 355: 479-489
4. 4. Cadet JL, Last R, Kostic V, Przedborski S, Jackson-Lewis V (1991) Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen. Brain Res Bull 26: 707-713
5. 5. Cadet JL, Zhu SM (1992) The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat. Brain Res 595: 316-326
6. 6. Carman LS, Gage FH, Shults CW (1991) Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res 553: 275-283
7. 7. Choi-Lundberg DL, Lin Q, Schallert T, Crippens D, Davidson BL, Chang Y-N, Chiang YL, Qian J, Bardwaj L, Bohn MC (1998) Behavioral and cellular protection of rat dopaminergic neurons by an adenovial vector encoding glial cell line-derived neurotrophic factor. Exp Neurol 154: 261-275
8. 8. Date I, Aoi M, Tomita S, Collins F, Ohmoto T (1998) GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice. Neuroreport 9: 2365-2369
9. 9. Date I, Felten DL, Felten SY (1990) Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis. Brain Res 519: 266-276
10. 10. Date I, Felten SY, Felten DL (1990) Cografts of adrenal medulla with peripheral nerve enhance the survivability of transplanted adrenal chromaffin cells and recovery of the host nigrostriatal dopaminergic system in MPTP-treated young adult mice. Brain Res 537: 33-39
11. 11. Date I, Miyoshi Y, Imaoka T, Furuta T, Asari S, Ohmoto T (1994) Efficacy of pretransection of peripheral nerve for promoting the survival of cografted chromaffin cells and recovery of host dopaminergic fibers in animal models of Parkinson's disease. Neurosci Res 20: 213-221
12. 12. Date I, Yoshimoto Y, Miyoshi Y, Imaoka T, Furuta T, Asari S, Ohmoto T (1993) The influence of donor age on cografting of adrenal medulla with pretransected peripheral nerve. Brain Res 624: 233-238
13. 13. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380: 252-255
14. 14. Hudson JL, van Horne CG, Stromberg I, Brock S, Clayton J, Masserano J, Hoffer BJ, Gerhardt GA (1993) Correlation of apomorphine-and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626: 167-174
15. 15. Kearns CM, Gash DM (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res 672: 104-111
16. 16. Lapchak PA, Gash DM, Jiao S, Miller PJ, Hilt D (1997) Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease. Exp Neurol 144: 29-34
17. 17. Lapchak PA, Jiao S, Collins F, Miller PJ (1997) Glial cell line-derived neurotrophic factor: distribution and pharmacology in the rat following a bolus intraventricular injection. Brain Res 747: 92-102
18. 18. Lapchak PA, Jiao S, Miller PJ, Williams LR, Cummins V, Inouye G, Matheson CR, Yan Q (1996) Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases. Cell Tis Res 286: 179-189
19. 19. Lindner MD, Winn SR, Baetge EE, Hammang JP, Gentile FT, Doherty E, McDermott PE, Frydel B, Ullman MD, Schallert T (1995) Implantation of encapsulated catecholamine and GDNF-producing cells in rats with unilateral dopamine depletions and parkinsonian symptoms. Exp Neurol 132: 62-76
20. 20. Paxinos G, Watoson C (1986) The rat brain in stereotaxic coordinates. Academic Press, New York
21. 21. Stromberg I, Bjorklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer B, Humpel C (1993) Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol 124: 401-412
22. 22. Tomac A, Lindqvist E, Lin LF, Ogren SO, Young D, Hoffer BJ, Olson L (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335-339
23. 23. Ungerstedt U (1971) Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Physiol 367: 69-93
24. 24. Watson R Jr., Wiegand SJ, Clough RW, Hoffman GE (1986) Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 7: 155-159
25. 25. Williams LR, Inouye G, Cummins V, Pelleymounter MA (1996) Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: dose-response comparison to nerve growth factor and brain-derived neurotrophic factor. J Pharmacol Exp Ther 277: 1140-1151